References
- Crews KR , HicksJK, PuiCH, RellingMV, EvansWE. Pharmacogenomics and individualized medicine: translating science into practice. Clin. Pharmacol. Ther.92(4) , 467–475 (2012).
- Scott SA . Clinical pharmacogenomics: opportunities and challenges at point of care. Clin. Pharmacol. Ther.93(1) , 33–35 (2013).
- Relling MV , KleinTE. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin. Pharmacol. Ther.89(3) , 464–467 (2011).
- Roberts JD , WellsGA, Le May MR et al. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. Lancet379(9827) , 1705–1711 (2012).
- Henrikson NB , BurkeW, VeenstraDL. Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J.8(2) , 85–89 (2008).
- Westbrook MJ , WrightMF, van Driest SL et al. Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing. Genet. Med. doi:10.1038/gim.2012.147 (2012) (Epub ahead of print).
- Sturm AC , ManickamK. Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”. J. Genet. Counsel.21(3) , 402–412 (2012).
- Salari K . The dawning era of personalized medicine exposes a gap in medical education. PLoS Med.6(8) , e1000138 (2009).
- Stanek EJ , SandersCL, TaberKA et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin. Pharmacol. Ther. 91(3) , 450–458 (2012).
- Haga SB , BurkeW, GinsburgGS, MillsR, AgansR. Primary care physicians‘ knowledge of and experience with pharmacogenetic testing. Clin. Genet.82(4) , 388–394 (2012).
- Haga SB , TindallG, O‘DanielJM. Professional perspectives about pharmacogenetic testing and managing ancillary findings. Genet. Test Mol. Biomarkers16(1) , 21–24 (2012).
- Becquemont L , AlfirevicA, AmstutzU et al. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB conference on pharmacogenetics and pharmacogenomics. Pharmacogenomics 12(1) , 113–124 (2011).
- Kitzmiller JP , EmbiPJ, ManickamK et al. Program in pharmacogenomics at the Ohio State University Medical Center. Pharmacogenomics 13(7) , 751–756 (2012).
- Sweet K , MichaelisR. The Busy Physician‘s Guide to Genetics, Genomics and Personalized Medicine (1st Edition). Springer Press, NY, USA (2011).
- Belmont J , McguireAL. The futility of genomic counseling: essential role of electronic health records. Genome Med.1(5) , 48 (2009).
- Samwald M , AdlassnigKP. Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes. J. Am. Med. Inform. Assoc.20(3) , 409–412 (2013).
- O‘Daniel JM . The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. J. Genet. Couns.19(4) , 315–327 (2010).
- Haga SS , O‘DanielJM, TindallGM, MillsR, LipkusIM, AgansR. Survey of genetic counselors and clinical geneticists‘ use and attitudes toward pharmacogenetic testing. Clin. Genet.82(2) , 115–120 (2012).
- Crews KR , CrossSJ, McCormickJN et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am. J. Health Syst. Pharm. 68(2) , 143–150 (2011).
- Callard A , NewmanW, PayneK. Delivering a pharmacogenetic service: is there a role for genetic counselors? J. Genet. Couns.21(4) , 527–535 (2012).